Verici Dx PLC (LSE:VRCI)
£ 0.0035 (0%) Market Cap: 8.01 Mil Enterprise Value: 5.65 Mil PE Ratio: 0 PB Ratio: 1.17 GF Score: 0/100

Half Year 2025 Verici DX PLC Earnings Call Transcript

Oct 07, 2025 / 09:00AM GMT
Release Date Price: £0.00725
Operator

Good morning, and welcome to the Verici Dx plc interim results investor presentation. (Operator Instructions)

Before we begin, we would like to submit the following poll. I'd now like to hand you over to CEO, Sara Barrington. Good morning.

Sara Barrington
Verici DX PLC - Chief Executive Officer, Executive Director

Good morning, everybody. And I will just move to the slides. Thank you. Just want to welcome everybody to the interim roadshow for the first half of 2025 and also a follow-up meeting after our financing event, which closed two months ago. So just as a quick reminder about who Verici is, we are a kidney transplant company with three products, two of which are commercialized. And we are at a pivotal point. The last financing was enabling us to move from a milestone-based company into a commercial growth company. We are moving forward on that.

So the company has raised GBP37.5 million to date to walk through the -- all the milestones to get to commerciality. And we have two products. I will go through the products in due course. But

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot